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Are We Asking The
Right Questions?
Candace Robertson-James, DrPH
Danielle Sands, MPH

Opioid Use Disorders/ Addiction
Opioids are a class of drugs that include the illicit drug heroin as well as
the licit prescription pain relievers oxycodone, hydrocodone, codeine,
morphine, fentanyl and others.1

Opioids interact with opioid receptors on nerve cells in the brain and
nervous system to produce pleasurable effects and relieve pain.1
Symptoms include2:
strong desire for
opioids

1American

inability to control
or reduce use

continued use
despite
interference with
major obligations
or social
functioning

use of larger
amounts over time

development of
tolerance

withdrawal
symptoms that
occur after
stopping or
reducing use

Society of Addiction Medicine, (https://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf) 2 https://www.samhsa.gov/disorders/substance-use

Philadelphia Statistics
• As of July 2017, Philadelphia ranked 5th in overdoes
deaths
• For all deaths in Philadelphia, overdoes is the leading
cause, specifically due to the use of Fentanyl
• In 2015, Philadelphia’s rate of 46.8 drug overdose deaths
per 100,000 residents far outpaced other large cities,
such as Chicago (15.4) and New York City (11.2)
• 80% of drug overdose deaths in Philadelphia involve
opioids, including prescription opioids, heroin, and
fentanyl.
McDaniel, J. (2017). Pa. overdose deaths again rise, but Philly no longer No. 1. Philadelphia,
PA: The Inquirer.
The Mayor’s Task Force to Combat the Opioid Epidemic, 2017

Prescription Pain Reliever Misuse

Figure 1. Past year misuse of prescription pain
relievers among adults aged 18 or older: 2015
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey
on Drug Use and Health (NSDUH), 2015

Figure 2. Main reasons for last episode of prescription pain reliever
misuse among past year misusers aged 18 or older: 2015
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health (NSDUH),
2015.

8 - 12% develop an opioid use disorder
(Muhuri et al., 2013; Cicero et al., 2014; Carlson et al., 2016)

An estimated 4 - 6 % who misuse prescription opioids transition to heroin
(Muhuri et al., 2013; Cicero et al., 2014; Carlson et al., 2016)

80% of people who use heroin first misused prescription opioids
(Muhuri et al., 2013)

Medication Assisted Treatment & Overdose
Prevention
• Methadone, Buprenorphine, Naltrexone
• Naloxone can temporarily reverse an overdose that is caused by an
opioid
• Naloxone blocks effects of opioids on the brain & restores breathing
within two to eight minutes
• Philadelphia, naloxone has been widely used and distributed:
• administered approximately 4,000 times by the Fire Department &
200 times by Philadelphia police in 2016.

Cases & Discussion

Cases

Case 1
Prescription
Opioids & the
Epidemic

Case 2
Naloxone –
Who pays for
it?

Case 3
ACES &
substance
misuse risk

Case 4
Substance Use
& Adolescence
/ Young
Adulthood

Case 5
Syringe
Exchange
(Prevention
Point)

Case 6
Veterans &
Opioid Misuse
Risk

HHS & NIH Priorities
• Improving access to treatment and recovery services
• Promoting use of overdose-reversing drugs
• Strengthening our understanding of the epidemic through better
public health surveillance
• Providing support for cutting-edge research on pain and addiction
• Advancing better practices for pain management
National Institute on Drug Abuse, 2017
(https://www.drugabuse.gov/drugs-abuse/opioids/opioid-crisis#six)

Recommendations for Philadelphia
•
•
•
•
•
•
•
•
•
•

Consumer directed media campaign about opioid risks
Public education campaign about Naloxone
Destigmatize opioid use disorder & its treatment
Improve health care provider education
Establish insurance policies that support safer opioid
prescribing and appropriate treatment
Increase provision of medication assisted treatment
Expand treatment access & capacity
Implement warm handoffs to treatment after overdose
Expand naloxone availability
Expand court’s capacity for diversion to treatment

Resources
• www.AmericanAddictionCenters.org (national)
• www.Discoveryplace.info (national)
• Tips for family and friends

• www.HealthyMindsPhilly.org (local)
• Support and programs for recovery

• www.PPPonline.org (local)
• Medical, shelter, meals, case management

• http://www.thehealingway.net/
• https://www.addiction-treatment.com/find/opiate/philadelphia-pa/

